Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Expert Opinion on Therapeutic Targets|May 27, 2023
Novel chromobox 2 inhibitory peptide decreases tumor progressionLindsay W Brubaker, Donald S Backos, Vu T Nguyen, et al.
Cancer Research Communications|December 4, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor ProgressionBradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto, et al.
Cancer Research Communications|March 7, 2024
Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 ExpressionLyndsey S Crump, Jessica L Floyd, Li-Wei Kuo, et al.
Cancer Research Communications|July 10, 2024
Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous CarcinomaRitsuko Iwanaga, Tomomi M Yamamoto, Karina Gomez, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Combinatory EHMT and PARP inhibition induces an interferon response and a CD8 T cell-dependent tumor regression in PARP inhibitor-resistant modelsLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Ablation of hematopoietic stem cell derived adipocytes reduces tumor burden in syngeneic mouse models of high-grade serous carcinomaElizabeth R Woodruff, Courtney A Bailey, Francis To, et al.
Molecular Cancer Therapeutics|June 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Molecular Cancer Therapeutics|May 7, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune ActivationLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Molecular Cancer Research : MCR|August 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent MannerLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Pageof 3